DLD's Strategic Q1 Portfolio Rebalance
DLD Asset Management Expands and Trims SPAC Holdings, Actively Adjusting Portfolio in Q1
Anonymous
Key Points
1
Bold Eagle Acquisition Corp. – Class A represents about 0.4% of DLD Asset Management LP's portfolio and is the 23rd-largest holding.
2
In Comstock Inc., two DLD directors made purchases on June 3: Robert Spence bought 24,410 shares at an average price of $3.97; Leo M. Drozdoff bought 7,000 shares at $4.11.
3
Evolution Global Acquisition Corp. (EVOX) received a new stake from DLD in Q1, acquiring 100,000 shares worth about $996,000.
4
Archimedes Tech SPAC Partners II Co. (ATII) saw DLD cut its stake by 25% to 150,000 shares, valued at about $1.56 million, and Weiss Ratings upgraded ATII from “sell (d-)” to “sell (d)” in May.
5
Churchill Capital Corp IX (CCIX) position was reduced by 23% to 200,862 shares (about $2.15 million); the stock also drew attention from other institutions (new or increased stakes) and rating actions turned more negative, with Weiss Ratings reaffirming a sell and Wall Street Zen rating CCIX as a sell.
DLD Asset Management LP made a flurry of moves across its SPAC holdings in the first quarter, buying new stakes, boosting existing ones, and trimming others. The firm now holds positions in at least five SPAC or micro-cap names, ranging from a $4.74 million bet on Bold Eagle Acquisition Corp. to a fresh $534,000 entry into Comstock Inc., according to Watchlist News.
SPACs — short for Special Purpose Acquisition Companies — are shell companies that raise money to merge with a private firm and take it public. DLD's Q1 filings show a clear strategy: go bigger on some names, pull back on others.
Bold Eagle and Cantor Equity See Big Boosts
DLD lifted its Bold Eagle Acquisition Corp. Class A stake by 28.3% in Q1, bringing its total to 448,952 shares worth about $4.74 million. Bold Eagle now ranks as DLD's 23rd-largest holding and makes up roughly 0.4% of its overall portfolio, Watchlist News reported.
The firm also made a massive move in Cantor Equity Partners V Inc. DLD bought 158,795 new shares of the stock, growing its stake by 1,085%. It now holds 173,430 total shares of the company, according to Ticker Report.
New Entries: Comstock and Evolution Global Added
DLD opened two brand-new positions during Q1. It bought 175,000 shares of Comstock Inc. for about $534,000, a stake worth roughly 0.23% of its holdings. Separately, it picked up 100,000 shares of Evolution Global Acquisition Corp. (EVOX) valued at about $996,000, per Watchlist News.
Comstock also saw insider buying around the same time. On June 3, two DLD-linked directors purchased shares. Robert Spence bought 24,410 shares at an average of $3.97 each. Leo M. Drozdoff added 7,000 shares at $4.11 apiece.
Churchill Capital and Archimedes Stakes Get Cut
DLD was not buying everywhere. It sold 60,000 shares of Churchill Capital Corp IX (CCIX) in Q1, cutting its position by 23%. The firm now holds 200,862 shares worth about $2.15 million. Ratings agencies have turned negative on CCIX — Weiss Ratings reaffirmed a sell rating, and Wall Street Zen also rates it a sell, Watchlist News reported.
DLD also trimmed its Archimedes Tech SPAC Partners II Co. (ATII) stake by 25%, selling 50,000 shares. It now holds 150,000 shares valued at roughly $1.56 million. Weiss Ratings did upgrade ATII in May — but only from a
What the Q1 Moves Signal About DLD's Approach
Taken together, DLD's Q1 filings paint a selective picture. The firm is not simply loading up on SPACs across the board. It is adding to names it likes — Bold Eagle, Cantor Equity — while cutting exposure to others like Churchill Capital and Archimedes. Two entirely new positions, Comstock and Evolution Global, show the firm is still hunting for fresh opportunities.
SPAC investing carries real risk. These shell companies often trade near their $10 trust value until a merger deal is announced. DLD's bets span several of these names, making its portfolio sensitive to deal activity and broader market sentiment around blank-check companies.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
14
Articles
11
Reach
25
A
AnonymousAuthor